[Advances in immortalization of human B cells]

Area of Science:

• Biotechnology and Immunology
• Monoclonal Antibody Production
• Cell Biology

Background:

• Human monoclonal antibodies are crucial in vivo therapeutics due to low immunogenicity and long half-lives.
• Immortalization of human B cells provides a natural source for generating human antibody libraries.
• Current B cell immortalization platforms for antibody preparation face challenges, limiting their application to laboratory research.

Purpose of the Study:

• To systematically review existing human B cell immortalization platforms for antibody preparation.
• To analyze the advantages, disadvantages, and feasibility of these platforms.
• To present an improved in vitro cell culture method using hCD40L vesicles.

Main Methods:

• Comprehensive literature review of human B cell immortalization techniques for antibody generation.
• Description of an in vitro cell culture system utilizing hCD40L vesicles.
• Comparison of the hCD40L vesicle method with traditional feeder cell-based approaches.

Main Results:

• Identified limitations in current B cell immortalization platforms hinder clinical translation.
• The hCD40L vesicle method offers a feeder-free alternative for in vitro culture.
• This approach aims to enhance the efficiency and scalability of human monoclonal antibody preparation.

Conclusions:

• Human B cell immortalization is a promising strategy for developing therapeutic antibodies.
• The novel hCD40L vesicle method presents a viable advancement for antibody preparation technology.
• Further development is needed to overcome current limitations and facilitate broader application.